IDEX Corporation provided earnings guidance for the year 2022. Full year 2022 organic sales growth is projected to be approximately 10%, with a 9% to 10% organic sales increase in the third quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.19 to $7.29 (adjusted EPS attributable to IDEX of $7.88 to $7.98) and third quarter 2022 reported EPS attributable to IDEX of $1.80 to $1.85 (adjusted EPS attributable to IDEX of $1.98 to $2.03).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
222.3 USD | +0.04% | -0.18% | +2.40% |
May. 16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
May. 08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.40% | 16.82B | |
-4.31% | 14.11B | |
+20.40% | 6.56B | |
+3.41% | 4.62B | |
+8.01% | 3.15B | |
+38.84% | 2B | |
+108.48% | 1.77B | |
+3.01% | 1.22B | |
+22.41% | 1.04B | |
-8.25% | 853M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Year 2022